What Essential Pre-Treatment Protocols And Documentation Should An Aesthetic Clinic Implement Prior To Conducting Fractional Laser Or Light-Based Skin Treatments? Optimize Safety & Compliance

Before any fractional laser or light-based treatment, the clinic should complete a documented medical assessment, obtain informed consent, prepare the skin appropriately, and verify room and device safety. The protocol should be adapted to the modality—ablative or non-ablative fractional laser, IPL, hair-reduction laser, or other device—and to the patient’s skin type, medical history, medications, and treatment goals.

Core takeaway: Safe treatment begins before the device is activated. A signed, procedure-specific record should demonstrate that the patient was screened, risks and expectations were discussed, contraindications were addressed, the skin was prepared, and the treatment environment was made safe.

Establish a Structured Pre-Treatment Assessment

Confirm identity, indication, and treatment goals

Verify the patient’s identity, treatment area, diagnosis or cosmetic indication, and desired outcome.

Document realistic expectations. Cosmetic outcomes cannot be guaranteed, and the patient should understand whether improvement is likely to be partial, gradual, or require multiple sessions.

Record relevant medical and skin history

The assessment should include:

Previous laser, IPL, chemical peel, or surgical procedures
History of herpes simplex, especially when treating the perioral region
Prior abnormal scarring, keloids, or hypertrophic scars
History of post-inflammatory hyperpigmentation or pigmentary disorders
Active acne, eczema, psoriasis, vitiligo, dermatitis, or other conditions that may worsen with injury
Active bacterial, viral, or fungal infection
Delayed wound healing, immune suppression, or poorly controlled systemic disease
Pregnancy or other patient-specific factors relevant to the proposed treatment

Active infection and significant untreated inflammation generally require postponement until the condition has resolved and the patient has been reassessed.

Review medications and allergies

Document prescription medicines, over-the-counter products, supplements, topical agents, and known allergies.

Pay particular attention to photosensitizing medications, anticoagulants or antiplatelet agents, topical retinoids, systemic retinoids, and drugs that may affect healing. Medication changes must be directed by the prescribing clinician; patients should not independently stop anticoagulants or other essential medicines.

For ablative resurfacing, specifically document any recent isotretinoin exposure and follow current specialist guidance and device protocols regarding treatment timing.

Assess skin type and treatment risk

Record the patient’s skin phototype and baseline pigmentation. Darker or recently tanned skin may have a higher risk of post-inflammatory hyperpigmentation after laser or light-based injury.

Use this assessment to select conservative, individualized parameters and determine whether a test patch or preparatory regimen is appropriate.

Prepare the Patient’s Skin

Enforce sun and tanning avoidance

Patients should avoid intentional tanning and minimize direct sun exposure before treatment. They should use a broad-spectrum sunscreen, protective clothing, and other sun-protection measures.

The required interval should reflect the treatment type, recent sun exposure, and clinic protocol. Treatment should be postponed if the area is sunburned or significantly tanned, because altered pigmentation increases the risk of burns and dyspigmentation.

Consider pigment-prevention protocols

For patients at increased risk of hyperpigmentation—particularly those with darker skin types or a history of pigmentary problems—the clinician may prescribe a pre-treatment depigmenting regimen such as hydroquinone.

This decision should be individualized, documented, and compatible with the planned device. Antioxidant or other topical regimens may also be used according to the clinician’s protocol, but they should not replace sun avoidance or appropriate parameter selection.

Use test patches where clinically appropriate

A test patch can help assess the patient’s response and refine fluence, pulse duration, density, or other settings before treating a larger area.

It is particularly useful when treating darker phototypes, pigmentary disorders, or patients with uncertain tolerance. The result and the decision to proceed should be recorded.

Address herpes simplex risk

Ask specifically about previous herpes simplex infections, even if the patient has not experienced a recent outbreak.

For susceptible patients—especially those receiving perioral, ablative, or more aggressive resurfacing—consider clinician-prescribed antiviral prophylaxis. The regimen and duration should follow current clinical guidance and be recorded in the treatment plan.

Provide written preparation instructions

Patients should receive written instructions covering:

Sun and tanning avoidance
Products or medications to pause, if clinically appropriate
Cleansing requirements
What to do if an infection, rash, sunburn, or cold sore develops
Whether topical anesthetic will be used and how it should be applied
Arrival instructions and the possibility of postponement if preparation requirements were not followed

Instructions should be signed or electronically acknowledged so the clinic can demonstrate that they were understood.

Complete Informed Consent and Baseline Documentation

Use procedure-specific informed consent

Consent should describe the actual proposed treatment rather than relying on a generic “laser consent” form.

It should cover:

Nature and purpose of the procedure
Device or modality being used
Expected benefits and likely number of sessions
Alternatives, including no treatment
Expected downtime and recovery
Short- and long-term risks
Pain, erythema, edema, crusting, blistering, infection, scarring, and delayed healing
Temporary or persistent hyperpigmentation, hypopigmentation, or worsening of melasma
Possible herpes reactivation
The possibility of incomplete response or the need for additional treatment
Costs, cancellation terms, and the elective nature of cosmetic treatment

The patient should have an opportunity to ask questions before signing. Consent is a process, not merely a signature.

Obtain standardized photographs

Take clear baseline photographs of the treatment area before treatment.

Use consistent lighting, positioning, camera settings, and background where possible. These images support clinical planning, objective outcome assessment, and documentation of pre-existing pigmentation or lesions.

Document financial and outcome expectations

Where appropriate, document that the patient understands the financial responsibility for elective treatment and that results cannot be guaranteed.

Avoid presenting waivers as a substitute for informed consent. A financial acknowledgment does not remove the clinic’s responsibility to explain material clinical risks.

Verify Treatment-Room and Device Safety

Confirm wavelength-specific eye protection

Everyone in the treatment room must use eye protection appropriate to the device’s wavelength and safety classification.

The patient requires the correct eye shields or eyewear for the treatment. Staff and observers require compatible laser safety eyewear, and ordinary protective glasses are not an adequate substitute.

Control access and reflections

For higher-powered systems, particularly Class 4 lasers, restrict room access during treatment.

Use appropriate warning signage and control reflective surfaces or windows so that the beam cannot be unintentionally redirected. The clinic should follow its local laser-safety officer, regulatory, and manufacturer requirements.

Prevent fire and chemical hazards

Clean the treatment area according to the clinic’s infection-control protocol, but ensure that any alcohol-based disinfectant has fully evaporated before the device is activated.

Residual flammable liquid or vapour can ignite when exposed to high-energy laser radiation. Avoid flammable materials, excess hair products, and improperly handled topical preparations in the beam path.

Prepare for plume and smoke

Ablative fractional lasers can generate surgical plume containing particulate matter and potentially infectious material.

Use a dedicated smoke evacuation system positioned close to the treatment site and appropriate respiratory protection in accordance with occupational-health guidance. General room ventilation alone may be insufficient.

Check the device and accessories

Before treatment, verify:

Device identity and service status
Correct handpiece, wavelength, and intended indication
Clean optical lenses, probes, and delivery components
Correctly configured fluence, pulse duration, spot size, density, or repetition rate
Functioning cooling or epidermal-protection systems
Availability of emergency supplies and post-treatment materials

The operator should complete a standardized pre-procedure checklist rather than relying on memory.

Record the Treatment Plan Before Activation

Document patient-specific settings

The planned record should include:

Treatment indication and area
Skin type and tone
Device and wavelength
Handpiece or tip
Energy or fluence
Pulse duration and repetition rate
Spot size, density, or coverage
Number of passes
Cooling method
Anesthetic used, including relevant timing and dose
Test-patch findings, if performed

The exact fields will vary by device, but the record must be sufficient to reproduce and evaluate the treatment.

Record the final pre-treatment check

Before firing the device, confirm and document that:

The patient has been correctly identified
Consent is complete
Contraindications have been reviewed
The treatment area is suitable
Eye protection is in place
Flammable products have evaporated
The device settings match the treatment plan
The patient has no new infection, rash, sunburn, or other reason to postpone

Understanding the Trade-offs

Do not apply one protocol to every device

Ablative CO₂ or Er:YAG resurfacing creates greater epidermal injury and usually requires more extensive screening, antiviral planning, wound-care preparation, and downtime counseling than many non-ablative fractional treatments.

IPL and hair-reduction lasers have different wavelength, pigment, and eye-safety considerations. A single generic checklist may omit risks specific to the device.

Avoid overly rigid medication rules

Some protocols impose fixed medication stoppages, but the correct decision depends on the drug, treatment depth, indication, and current evidence.

Do not instruct patients to stop anticoagulants, antiplatelet drugs, or systemic therapies without prescriber involvement. Record the clinical decision and rationale instead.

Balance pigment prevention against irritation

Depigmenting agents can reduce pigmentary risk in selected patients, but irritated or overtreated skin may respond poorly.

Use them only when clinically appropriate, monitor tolerance, and provide clear instructions about when to pause or resume them after treatment. Do not treat inflamed or compromised skin without reassessment.

Do not treat consent as a checklist exercise

A signed form does not prove that the patient understood the risks or that the treatment was appropriate.

The clinician must document the discussion, patient questions, individualized risks, and the decision to proceed or postpone.

How to Apply This to Your Clinic

Use a standardized workflow that combines patient screening, skin preparation, consent, safety verification, and parameter documentation.

If your primary focus is patient safety: Require a clinician-completed screening and room-safety checklist before every treatment, including infection review, eye protection, fire precautions, and device verification.
If your primary focus is reducing cancellations: Give patients written sun-avoidance, medication, skin-preparation, and postponement instructions well before the appointment.
If your primary focus is preventing pigmentary complications: Document skin phototype, recent tanning, prior hyperpigmentation, test-patch results, and any individualized depigmenting plan.
If your primary focus is legal and clinical traceability: Maintain signed consent, baseline photographs, medical history, exact settings, anesthesia details, skin response, and post-treatment instructions in the procedure record.
If your primary focus is consistent staff performance: Use modality-specific checklists based on the manufacturer’s instructions, local regulations, and the clinic’s medical director’s protocol.

A disciplined pre-treatment process protects the patient, improves treatment consistency, and gives the clinic defensible evidence that every procedure was carefully planned.

Summary Table:

Protocol Step	Key Documentation	Purpose
Medical & Skin History	Record previous treatments, herpes, scarring, pigmentation, infections, pregnancy	Identify risk factors
Medication Review	List all drugs, supplements, allergies; note photosensitizers	Adjust plan with prescriber
Skin Assessment	Record skin type, baseline pigmentation	Select safe parameters
Sun Avoidance	Enforce sun/tanning avoidance; use sunscreen	Prevent burns and dyspigmentation
Test Patch	Perform test patch if indicated	Refine settings
Herpes Prophylaxis	Prescribe antivirals if needed	Prevent reactivation
Informed Consent	Obtain procedure-specific consent	Ensure understanding of risks
Photographs	Take baseline images	Document outcome
Safety Checks	Verify eye protection, device, fire safety	Prevent injury
Parameter Documentation	Record exact settings	Reproduce treatment

Ready to elevate your clinic's safety standards? BELIS offers professional-grade aesthetic equipment and expert protocols. Contact us today to learn how we can support your practice with advanced laser systems and comprehensive training, ensuring optimal patient outcomes and business success.